(Q53328033)

13 May 2018

title

How statins could be evaluated successfully in clinical trials for Alzheimer's disease? (English)

1 reference

13 May 2018

author

Javier S. Burgos

1

1 reference

13 May 2018

author name string

Jesús Benavides

2

1 reference

13 May 2018

Patrice Douillet

3

1 reference

13 May 2018

Javier Velasco

4

1 reference

13 May 2018

Fernando Valdivieso

5

1 reference

13 May 2018

language of work or name

English

0 references

publication date

17 April 2012

1 reference

13 May 2018

American Journal of Alzheimer's Disease & Other Dementias

published in

1 reference

13 May 2018

volume

27

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

page(s)

151-153

1 reference

13 May 2018

Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1533317512442998

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512442998

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512442998

Apolipoprotein E: far more than a lipid transport protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512442998

How do statins control neuroinflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512442998

Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512442998

Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512442998

Statins and therapy of Alzheimer's disease: questions of efficacy versus trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512442998

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512442998

Cognitive impairment associated with atorvastatin and simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512442998

Midlife cardiovascular risk factors and risk of dementia in late life

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512442998

Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512442998

Age-varying association between statin use and incident Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512442998

Long-term statin therapy is associated with better episodic memory in aged familial hypercholesterolemia patients in comparison with population controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512442998

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512442998

ApoB100/LDLR-/- hypercholesterolaemic mice as a model for mild cognitive impairment and neuronal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512442998

A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512442998

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512442998

Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512442998

21 January 2018

Identifiers

DOI

10.1177/1533317512442998

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/otcie5tf7bddrpgzcbeyisyega

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_otcie5tf7bddrpgzcbeyisyega

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/otcie5tf7bddrpgzcbeyisyega

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/otcie5tf7bddrpgzcbeyisyega

1 reference